• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75656.0
  • ISIN : INE07RO01027
901.75 -16 (-1.71%)
  • As on 12 Sep 2026 (EOD)

  • Today’s Low

    891.25

  • Today’s High

    915.30

  • Open

    915.00

  • Perv Close

    917.45

  • 52W Low

    545.50

  • 52W High

    1,085.00

Key Indicators

  • P/E(TTM)

    36.61

  • Mar.Cap (₹Cr.)

    7,257.54

  • Div & Yield %

    0.11

  • Book Value(₹)

    148.82

  • Debt-Equity Ratio

    -1.71

  • AGM Date

    11-Sep-2026

  • EPS

    24.69

  • P/E Ratio

    36.61

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7,257.54

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.10

  • BV (₹)

    148.80

  • Sales( ₹ in Cr.)

    827.88

  • NP (in Cr.)

    209.15

  • NP Var(%)

    11.0

  • Div%

    50.0

  • CPS (₹)

    29.50

  • EPS (₹)

    26.00

  • Traded Value (₹ in Lakhs)

    7,274.44

  • 52 Week High

    1,085.00

  • 52 Week Low

    545.50

  • Price BSE

    904.0

  • Price NSE

    902.00

  • Market Capital( in Cr.)

    7,274.44

  • P/C Ratio

    30.60

  • P/E Ratio

    34.80

  • Price Vs.BV

    26.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 914.72 781.92 646.93 516.47 588.52 430.97
Excise Duty 86.85 85.44 76.59 55.53 58.47 39.76
Net Sales 827.87 696.48 570.34 460.94 530.05 391.21
Other Income 11.49 9.82 10.64 9.49 7.58 5.01
Stock Adjustments 11.09 21.26 -30.31 6.51 3.03 12.44
Total Income 850.45 727.56 550.67 476.94 540.66 408.66
EXPENDITURE :            
Raw Materials 265.12 232.44 191.43 187.32 198.83 140.57
Power and Fuel Cost 29.77 24.80 21.37 20.95 14.07 9.24
Employee Cost 96.68 80.52 67.64 55.58 49.08 32.76
Other Manufacturing Expenses 80.61 51.81 35.68 28.87 18.44 13.15
Selling and Administration Expenses 58.68 54.65 38.10 37.32 33.83 31.88
Miscellaneous Expenses 13.64 12.61 9.80 8.51 4.84 2.92
Employee Benefit Expenses 96.68 80.52 67.64 55.58 49.08 32.76
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 544.49 456.83 364.01 338.55 319.09 230.51
Operating Profit 305.96 270.73 186.65 138.38 221.56 178.15
Interest 2.77 1.81 5.15 3.08 4.20 4.08
Gross Profit 303.19 268.92 181.50 135.30 217.36 174.07
Depreciation 28.41 20.44 15.81 11.82 10.12 6.76
Profit Before Tax 274.78 248.48 165.69 123.48 207.24 167.31
Current Tax 61.43 56.66 37.10 30.68 52.19 43.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.23 3.87 9.48 2.95 3.25 0.69
Reported Net Profit 209.12 187.96 119.11 89.86 151.81 123.59
Extraordinary Items -0.03 0.00 0.00 -0.08 0.00 0.00
Adjusted Net Profit 209.15 187.96 119.11 89.94 151.81 123.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 781.97 600.45 486.16 401.13 253.72 134.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 8.05 6.44 4.83 4.83 4.39 3.96
P & L Balance carried down 983.04 781.97 600.45 486.16 401.13 253.72
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 40.00 30.00 30.00 27.00
Dividend Per Share(Rs) 1.00 1.00 0.80 0.60 0.60 0.54
Earnings Per Share-Unit Curr 25.98 23.35 14.80 11.16 18.86 16.89
Earnings Per Share(Adj)-Unit Curr 25.98 23.35 14.80 11.16 18.86 -
Book Value 148.81 123.84 101.31 86.91 76.50 36.70
Book Value(Adj)-Unit Curr 148.81 123.84 101.31 86.91 76.50 -

Shareholding Pattern

  • Promoter Group

    68.30%

  • Public Share Holding

    31.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,967,815 68.30 54,967,815 5
Partnership Firms-Indian (Promoter & Group) 10 0.00 10 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,967,825 68.30 54,967,825 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10 0.00 10 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,979,916 6.19 4,979,916 73
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,930,686 2.40 1,930,686 2
Mutual Funds / UTI 1,041,067 1.29 1,041,067 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,297,047 1.61 1,297,047 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,248,726 11.49 9,248,726 93
2] Non Institution
Bodies Corporate 1,749,209 2.17 1,749,209 405
Clearing Members 24,018 0.03 24,018 21
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 893,389 1.11 893,389 2,024
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 550,612 0.68 550,612 1,340
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,001,138 1.24 1,001,138 6
Individuals holding nominal share capital up to Rs. 1 lakh 11,859,761 14.74 11,859,761 78,117
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 10,496 0.01 10,496 3
Others 0 0.00 0 0
Sub Total 16,266,249 20.21 16,266,249 81,983
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 80,482,800 100.00 80,482,800 82,082

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Supriya Lifescience Ltd
  • BSE Code : 75656.0
  • ISIN : INE07RO01027

  • Incorporation Year

    2008

  • Registered Office

    207/208 Udyog Bhavan
    Sonawala Road Goregaon (East), Mumbai,
    Maharashtra-400063

  • Telephone

    91-22-40332727

  • FAX

  • Chairman

    Satish Waman Wagh

  • Managing Director

    Satish Waman Wagh

  • Company Secretary

    Prachi Sathe

  • Auditor

    Kakaria & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Supriya Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Supriya Lifesci. 903.85 839.36 914.72 36.67 25.13
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77